Exelixis Inc

+0.28 (+1.76%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)5.21B
Current PE19.10
Forward PE 17.59
2yr Forward PE 13.83
See more stats
Estimates Current Quarter
Revenue$411.83 Million
Adjusted EPS$0.23
See more estimates
10-Day MA$16.51
50-Day MA$18.93
200-Day MA$19.76
See more pivots

Exelixis Inc Stock, NASDAQ:EXEL

1851 Harbor Bay Parkway, Alameda, California 94502
United States of America
Phone: +1.650.837.7000
Number of Employees: 954


Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of COMETRIQ, CABOMETYX, COTELLIC, and MINNEBRO. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.